El Lilly’s (LLY) blockbuster weight-loss drug Zepbound is now eligible for Medicare coverage. The news could significantly ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

The first tip came into West Tennessee law enforcement about two months ago: A resident in the area was selling cheap versions of Ozempic and other weight loss drugs. According to officials with ...

Ozempic is synonymous with weight loss for many people, even as they can turn to drugs with other brand names that have been tailored to treat obesity. The blockbuster Type 2 diabetes medication ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Obesity rates decline in U.S. for first time in decade, driven by Souths medication usage Obesity decline signals potential ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the ...

The study stated that weight loss drugs can affect bone and muscle mass, leading to chronic illnesses and risk of fractures. For the longest time, people resorted to diet and exercise for losing ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.The medicine, part of the class known as GLP-1 ...